mRNA-4157,Pembrolizumab
Moderna,Merck
['lcsm,(-blcsm)', 'key,note,42', 'mrna-4157', 'lung', 'key,note,57', 'keynote,942', 'melanoma', 'pembro']
mrna-4157-p201/keynote-942: pembrolizumab +/- mrna-4157 (v940, personalized cancer vaccine) as adjuvant therapy in resectable melanoma, a randomized phase 2, open-label study by dr. jeffrey weber. what happens in melanoma will happen in lung cancer. #aacr23 #lcsm 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC